BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Beds

Below is an extended Beds research listing. Click here to return to the Beds main in depth entry.

Recent Publications on Beds:

Support surfaces for pressure ulcer prevention.
BACKGROUND: Pressure ulcers (also known as bedsores, pressure sores,...
Direct Link
10th October, 2008
49 St Davids Road, Haberfield, New South Wales, Australia, 2045.
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Gadolinium (Gd) based contrast agents (GBCAs) in magnetic resonance...
Direct Link
10th October, 2008
[1] 1Department of Neurology and Neurosurgery, Oregon Health and Science
[Gender bias in women with myocardial infarction: ten years after.] 10th October, 2008
Servicio de Medicina Intensiva. Hospital de Sagunto. Valencia. Espana.
Activity and analysis of costs in a dedicated weaning centre. 8th October, 2008
Institute of Respiratory Diseases, University of Modena-Reggio Emilia,
Nerve Stimulation Induced Overflow of Neuropeptide Y and Modulation by Angiotensin II in Spontaneously Hypertensive Rats.
The sympathetic nervous system (SNS) and the renin angiotensin system...
Direct Link
7th October, 2008
Saint Louis University.
Patient, Hospital, and Procedure Characteristics Influencing Total Hip and Knee Arthroplasty Procedure Duration.
Procedure duration is a potential risk factor for total hip arthroplasty...
Direct Link
7th October, 2008
Exponent, Inc, Philadelphia, Pennsylvania.
[Glycopeptid-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones.]
AIM OF THE STUDY: To describe specific difficulties to control a...
Direct Link
7th October, 2008
Laboratoire de microbiologie, hopital Bel-Air, centre hospitalier regional
Kaolinite flocculation structure.
Effective flocculation and dewatering of mineral processing streams...
Direct Link
7th October, 2008
Ian Wark Research Institute, University of South Australia, Mawson Lakes,
A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: Pre- and post-severe acute respiratory syndrome.
BACKGROUND: The Resources for Infection Control in Hospitals (RICH)...
Direct Link
7th October, 2008
Department of Pathology and Molecular Medicine, Queen's University and
Infection control resources in New York State Hospitals, 2007.
BACKGROUND: In July 2005, New York State legislation requiring the...
Direct Link
7th October, 2008
New York State Department of Health, Albany, NY.
A user assessment of a smaller hospital surveillance program.
Forty-five infection control nurses responded to a survey that assessed a...
Direct Link
7th October, 2008
Victorian Nosocomial Infection Surveillance System (VICNISS) Co-ordinating
Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes is Opposed by Compensatory Overexpression of COX-2 in the Vasculature.
Cardiovascular complications of diabetes result from endothelial...
Direct Link
29th July, 2008
Department of Pharmacology and Human Physiology - Medical School -
Retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and number of psychiatric beds in England 1996-2006. 29th July, 2008
East Community Mental Health Team, Molineux Street NHS Centre, Newcastle
Availability of inpatient beds for psychiatric admissions in the NHS. 29th July, 2008
Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain.
Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA)...
Direct Link
29th July, 2008
Infectious Diseases Service, Hospital Universitari de Bellvitge,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional